EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Statins The Hmg Coa Reductase Inhibitors In Perspective 2nd Edition Allan Gaw

Name: Statins The Hmg Coa Reductase Inhibitors In Perspective 2nd Edition Allan Gaw
SKU: BELL-2012568
Price: 31.00 USD
Availability: InStock
Rating: 4.1 (90 reviews)

SKU: BELL-2012568

$ 31.00 ~~$ 45.00~~ (-31%)

4.1

90 reviews

Statins The Hmg Coa Reductase Inhibitors In Perspective 2nd Edition Allan Gaw instant download after payment.

Publisher: CRC Press

File Extension: PDF

File size: 4.69 MB

Pages: 272

Author: Allan Gaw, Chris J. Packard, James Shepherd

ISBN: 9781841842929, 1841842923

Language: English

Year: 2003

Edition: 2

Product desciption

Statins The Hmg Coa Reductase Inhibitors In Perspective 2nd Edition Allan Gaw by Allan Gaw, Chris J. Packard, James Shepherd 9781841842929, 1841842923 instant download after payment.

Building upon the foundation set in the first edition, Statins: The HMG-CoA Reductase Inhibitors in Perspective examines existing and emerging statins and their beneficial effectiveness in reducing serum cholesterol. The breadth of coverage and depth of information in this book provide an authoritative guide to statins from their discovery through the major clinical trials to the present and explores the future of statin trials and lipid-lowering therapy beyond statins. The book tells the story of statins, for the most part in the words of those who lived it. The major clinical trials from Scandinavia, North America, Australia, New Zealand, and Scotland are detailed by those who conducted them.